• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Eukaryotic translation initiation factor 1A, X-chromosomal (EIF1AX)

ACP00473

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP00473 Target NameEIF1AX
Target SynonymseIF-1A X isoform;Eukaryotic translation initiation factor 4C;eIF-4CFormLiquid or Lyophilized powder
Expression SystemE.coliExpression Range1-144aa
Mol Weight23.4 kDaProtein LengthFull length
PurityGreater than 95% as determined by SDS-PAGE.Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP47813
Background Information
  • Uniprot Id

    P47813

  • Target Species

    Human

  • Target Name

    EIF1AX

  • Target Full Name

    Eukaryotic translation initiation factor 1A, X-chromosomal

  • Target Function

    Seems to be required for maximal rate of protein biosynthesis. Enhances ribosome dissociation into subunits and stabilizes the binding of the initiator Met-tRNA(I) to 40 S ribosomal subunits.

  • Target Protein Families

    EIF-1A family

  • Target Research Area

    Epigenetics and Nuclear Signaling

  • Target Synonyms

    EIF1AX; EIF1A; EIF4C; Eukaryotic translation initiation factor 1A; X-chromosomal; eIF-1A X isoform; Eukaryotic translation initiation factor 4C; eIF-4C

  • Target Background

    This gene encodes an essential eukaryotic translation initiation factor. The protein is required for the binding of the 43S complex (a 40S subunit, eIF2/GTP/Met-tRNAi and eIF3) to the 5' end of capped RNA.

Inquire Recombinant Human Eukaryotic translation initiation factor 1A, X-chromosomal (EIF1AX) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification